Tim Schmeiser
Tim Schmeiser publishes mostly in Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology, on topics such as Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Inflammatory Myopathies and Dermatomyositis.
- World rank
- #711,151 of 7,710,434 ranked researchers
- Rank in Germany
- #35,063 of 364,343
- Works
- 86
- Citations
- 1.1k
- Citations per work
- 13.1
What does Tim Schmeiser research?
Tim Schmeiser's work is mostly in Medicine (72%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6272.5%
- Medicine6272.5%
- Everything else2427.5%
- 1Pathology and Forensic Medicine30% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Rheumatology8% of their works
- 4Epidemiology8% of their works
- 5Infectious Diseases6% of their works
- 6Surgery6% of their works
Research topics
- Systemic Sclerosis and Related Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inflammatory Myopathies and Dermatomyositis
- Long-Term Effects of COVID-19
- Multiple Sclerosis Research Studies
- Rheumatoid Arthritis Research and Therapies
- COVID-19 Clinical Research Studies
- Medical Imaging and Pathology Studies
Which keywords describe Tim Schmeiser's research?
The keywords of their largest research topics: Autoantibodies, Fibrosis, Treatment, Pulmonary Involvement, Systemic Sclerosis, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis and TGF-ß.
- Pulmonary Alveolar Microlithiasis
- Clinical Characteristics
- Post-acute COVID-19 Syndrome
- Multiple Sclerosis
- Diagnostic Criteria
- Dermatomyositis
- TGF-ß
- Interstitial Lung Disease
- Pulmonary Involvement
- Fibrosis
- Autoantibodies
- Treatment
- Systemic Sclerosis
- Idiopathic Pulmonary Fibrosis
- Cognitive Impairment
- Inflammatory Myopathies
- Inflammation
- Neurologic Manifestations
- Rheumatoid Arthritis
- SARS-CoV-2
- Pulmonary Sclerosing Hemangioma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Autoantibodies823 topics
- Fibrosis792 topics
- Treatment732 topics
- Pulmonary Involvement581 topic
- Systemic Sclerosis581 topic
- Interstitial Lung Disease362 topics
- Idiopathic Pulmonary Fibrosis211 topic
- TGF-ß211 topic
- Cognitive Impairment182 topics
- Dermatomyositis151 topic
- Inflammatory Myopathies151 topic
- Diagnostic Criteria91 topic
- Inflammation91 topic
- Multiple Sclerosis91 topic
- Neurologic Manifestations91 topic
- Post-acute COVID-19 Syndrome91 topic
- Rheumatoid Arthritis91 topic
- Clinical Characteristics81 topic
- SARS-CoV-281 topic
- Pulmonary Alveolar Microlithiasis71 topic
- Pulmonary Sclerosing Hemangioma71 topic
Where does Tim Schmeiser work?
Tim Schmeiser's main affiliation in the publication record is Kerckhoff Klinik, Germany.
How many publications and citations does Tim Schmeiser have?
OpenAlex counts 86 works and 1,127 citations for Tim Schmeiser, an h-index of 20, ranking #711,151 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tim Schmeiser. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.